Scientists probe immune Cells' role in scleroderma blood vessel injury
NCT ID NCT02636127
First seen May 09, 2026 · Last updated Jun 19, 2026 · Updated 7 times
Summary
This study looks at how certain immune cells, called T cells and NK cells, may harm blood vessels in people with systemic sclerosis (scleroderma). Researchers will analyze blood samples from 30 participants, including patients and healthy volunteers, to measure a protein called Fractalkine and study cell interactions. The goal is to better understand the disease, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCLERODERMA, SYSTEMIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Assistance Publique Hopitaux de Marseille
Marseille, 13354, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could point toward new treatment targets for systemic sclerosis by clarifying how immune cells injure blood vessels.
What could go wrong
This is a small, observational study with only 30 participants, so findings may not apply to all patients. It is early-stage research, not a treatment trial.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.